MediPharm Labs Announces OTC Ticker Symbol Change to “MEDIF”

Apr 9, 2019

MediPharm Labs Assembles Globally Renowned Experts to Form Scientific Advisory Committee

Apr 8, 2019

MediPharm Labs Reports Q4 2018 Revenue of $10.2 Million and Adjusted EBITDA of $2.1 Million

Apr 3, 2019

MediPharm Labs Acquires Over 5,000 KG of Dried Cannabis for Private Label Cannabis Oil Production and Launches New White Label Solutions Platform

Apr 1, 2019

MediPharm Labs Sets Date to Release Fourth Quarter and Full Year 2018 Financial Results

Mar 27, 2019

MediPharm Labs Expands Legal Team Adding Cannabis Expertise and Announces Participation at Upcoming Conferences

Mar 26, 2019

MediPharm Labs Signs First International Private Label Sale Agreement With AusCann for Cannabis Oil Export to Australia

Feb 21, 2019

MediPharm Labs Announces Listing on Frankfurt Stock Exchange

Feb 19, 2019

MediPharm Labs Signs $35 Million Private Label Cannabis Oil Sale Agreement with Option for Additional $13.5 Million

Feb 12, 2019

MediPharm Labs Aligns Leadership and Organizational Structure  For Future Prosperity of Company

Feb 5, 2019